CLINICAL_TRIALS trial_result · 2018-06-12

Clinical Trial Update: A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus [Phase 2]

Phase 2a trial evaluating the efficacy and safety of ustekinumab in systemic lupus erythematosus has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Research & Development, LLC | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2018-06-12